59 results
Page 2 of 3
424B7
c3g06s63yx4gs 3i8
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
tngcdz jtu3
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K
EX-99.2
yfynpold t0fa
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
EX-99.1
be6pyokv2urv
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
EX-99.2
if1eyiqxz26rpsgbks
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
jvi69o
27 Jul 21
Current report (foreign)
6:12am
6-K
EX-99.1
fhctya
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.3
2jnpj1jz4j1two96yi
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.2
hmim uf86
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
6d7okjbdoz
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
424B5
8yitxqkzop8ts 14c5l
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-99.1
zurd0f2gvv1vgkrt
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
EX-99.1
r0usgtw
10 Feb 21
ObsEva Provides Business Outlook for 2021
6:10am
424B5
mk10gs 4qrb3zkgg
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.1
j4a pqi7jji
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
t5tx et03et5dq
1 Jul 20
ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA
6:15am
6-K
EX-99.1
a90pp
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am